NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 23 04:00PM ET
0.6879
Dollar change
-0.0411
Percentage change
-5.64
%
Index- P/E- EPS (ttm)-0.37 Insider Own0.00% Shs Outstand4.19M Perf Week-17.62%
Market Cap3.66M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-49.04%
Enterprise Value1.11M PEG- EPS next Q- Inst Own0.02% Short Float- Perf Quarter-99.51%
Income-1.55M P/S- EPS this Y- Inst Trans- Short Ratio0.34 Perf Half Y-99.74%
Sales0.00M P/B0.55 EPS next Y- ROA-50.61% Short Interest0.93M Perf YTD-99.87%
Book/sh1.26 P/C1.44 EPS next 5Y- ROE-57.83% 52W High1200.00 -99.94% Perf Year-
Cash/sh0.48 P/FCF- EPS past 3/5Y-29.52% - ROIC-29.23% 52W Low0.55 25.07% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility2.43% 18.77% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-157.55% Oper. Margin- ATR (14)6.69 Perf 10Y-
Dividend Ex-Date- Quick Ratio10.16 Sales Y/Y TTM- Profit Margin- RSI (14)35.22 Recom-
Dividend Gr. 3/5Y- - Current Ratio10.16 EPS Q/Q-134.05% SMA20-18.77% Beta- Target Price-
Payout- Debt/Eq0.00 Sales Q/Q- SMA50-98.64% Rel Volume0.12 Prev Close0.73
Employees6 LT Debt/Eq0.00 Earnings- SMA200-99.66% Avg Volume2.69M Price0.69
IPOOct 29, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume336,143 Change-5.64%
Jun-12-25 07:32AM
May-23-25 04:15PM
May-21-25 07:10AM
May-13-25 07:45AM
May-03-25 11:00AM
07:37AM Loading…
Apr-25-25 07:37AM
Apr-11-25 04:15PM
Apr-02-25 09:05AM
Apr-01-25 04:09PM
Mar-31-25 09:32AM
Mar-27-25 08:25AM
Mar-25-25 04:04PM
Mar-21-25 11:50AM
Mar-19-25 07:35AM
Mar-14-25 08:35AM
07:51AM Loading…
Mar-13-25 07:51AM
Mar-11-25 04:27PM
Mar-10-25 07:47AM
Jan-30-25 05:55AM
Jan-23-25 06:40AM
Dec-30-24 06:25AM
Dec-19-24 07:22AM
Dec-18-24 06:25AM
Dec-13-24 06:25AM
Dec-02-24 08:02AM
Oct-30-24 01:50PM
10:28AM
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.